The FTSE 100 stagnates as Rio Tinto and healthcare stocks weigh on the market


The FTSE 100 was little changed at 0718 GMT, with Rio Tinto falling 3.5% as the miner traded without the right to a final dividend payment.

Drugmaker GSK slid 2.1% after strong sales in the previous session amid talk of the potential negative implications of US lawsuits over Zantac, a drug that was withdrawn in 2019. Haleon, a consumer healthcare company recently spun off from GSK, fell 4.9%.

Shares of London-listed Antofagasta slid 0.5% after the Chilean miner reported a drop in half-year profit.

The domestically focused FTSE 250 index rose 0.4% as European and Asian stocks rose.

Shares of Network International, a Dubai-based, UK-listed payment processor, jumped 11.3% after announcing a share buyback program and posting strong half-year results.



Source link -88